Transgenic mouse models of rheumatoid arthritis

Immunological Reviews

Volumn 169, Issue , 1999, Pages 161-173

  Holmdahl, Rikard ^c   Andersson, Ellen Christina ^a   Andersen, Claus B ^a   Svejgaard, Arne ^a   Fugger, Lars ^b  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; COLLAGEN TYPE 2; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; RHEUMATOID ARTHRITIS; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ARTHRITIS, RHEUMATOID; COLLAGEN; DISEASE MODELS, ANIMAL; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; MICE; MICE, TRANSGENIC; MODELS, MOLECULAR; T-LYMPHOCYTES;

EID: 0032796647     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01314.x     Document Type: Review

References (83)

1. 1. Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA. Involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type II arthritis in mice. Proc Natl Acad Sci USA 1992;89:7375-7379.
2. 2. Williams R, Feldman M, Maini R. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc: Natl Acad Sci USA 1992;89:9784-9788.
3. 3. Wooley PH, et al. The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis in mice. Arthritis Rheum 1993,36:1305-1314.
4. 4. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
5. 5. Stasmy P. Association of the B-cell alloantigen DR(1)4 with rheumatoid arthritis. N Engl J Med 1978;298:869-871.
6. 6. Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI. HI.A DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci USA 1989;86:10049-10053.
7. 7. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arihritis Rheum 1987;30:1205-1213.
8. 8. Cook AD, Rowley MJ, Mackay IR Gough A, Emery P. Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression. Arthritis Rheum 1996;39:1720-1727.
9. 9. Rönnelid J, Lysholm J, Engström-Lauront A, Klareskog L, Heyman B, Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum 1994;37:1023-1029.
10. 10. Morgan K, Clague RB, Collins I, Ayad S, Phinn SD, Holt PJL. A longitudinal study of anticollagen antibodies in patients with rheumatoid arthritis. Arthritis Rheum 1989;32;139-145.
11. 11. Holmdahl R. Type II collagen in the pathogenesis of rheumatoid arthritis. In: Smolen JS, Kalden JR, Maini RN, eds. Rheumatoid arthritis. Berlin: Springer Verlag: 1992. p. 180-201.
12. 12. Guerassimov A, et al. Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. Arthritis Rheum 1998;41:1019-1025.
13. 13. Molberg O, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized hy gut-derived T cells in celiac disease. Nat Med 1998;4:713-717.
14. 14. Aeschlimann D, Kaupp O, Paulsson M. Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate. J Cell Biol 1995;129;881-892.
15. 15. Michaëlsson E, Malmström V, Reis S, Burkhardt H, Engström Å, Holmdahl R. T cell recognition of carbohydrates on type II collagen. J Exp Med 1994;30:745-749.
16. 16. Michaëlsson E, Broddefalk J, Kihlberg J, Engström Å, Holmdahl R. Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells. Eur J Immunol 1996:26;1906-1910.
17. 17. Corthay A, et al. Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. Eur J Immunol 1998;28:2580-2590.
18. 18. Nepom GT, Erlich H. MHC class II molecules and autoimmunity. Annu Rev Immunol 1991;9:493-525.
19. 19. Roudier J, Rhodes G, Petersen J, Vaughan JH, Carson DA. The Epstein Barr virus glycoprotein gp110, a molecular link between HLADR4, HLADR1, and rheumatoid arthritis. Scand J Immunol 1988;27:367-371.
20. 20. Roudier J, Petersen J, Rhodes GH, Luka J, Carson DA. Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dω4 DR β-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci USA 1989;86:5104-5108.
21. 21. Zanelli E, Gonzalez Gay MA, David CS. Could HLA-DRB l be the protective locus in rheumatoid arthritis? Immunol Today 1995;16:274-278.
22. 22. Walser Kuntz DR, Weyand CM, Weaver AJ, O'Fallon WM, Goronzy JJ. Mechanisms underling the formation of the T cell receptor repertoire in rheumatoid arthritis. Immunity 1995;2:597-605.
23. 23. Zanelli E, Krco CJ, David CS. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition. J Immunol 1997;158:3545-3551.
24. 24. Jawaheer D, et al. "Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis oncordance in identical twins. Arthritis Rheum 1994;37:681-686.
25. 25. Evans TI, Huri J, Singh R, Moxley G. The genotypic distribution of shared-epitope DRB1 alleles suggests a recessive mode of inheritance of the rheumatoid arthritis disease-susceptibility gene. Arthritis Rheum 1995;38:1754-1761.
26. 26. Cremer MA, Rosloniec EF, Kang AH. The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. J Mol Mod 1998;76:275-288.
27. 27. Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in Balb/c mice. Arthritis Rheum 1987:30:201-212.
28. 28. Zhang Y, et al. Induction of arthritis in BALB/c mice by cartilage link protein; involvement of distinct regions recognizerd by T and B lymphocytes. Am J Pathol 1998:153:1283-1291.
29. 29. Carlsen S, Hansson AS, Olsson H, Heinegård D, Holmdahl R. Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats. Clin Exp lmmunol 1998;114:477-484.
30. 30. Wordsworth P, et al. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet 1992:51:585-591.
31. 31. Lanchbury JS, et al. Strong primary selection for the Dω4 subtype of DR4 accounts for the HLA-DQω7 association with Felty's syndrome. Hum Immunol 1991:32:56-64.
32. 32. Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120-2126.
33. 33. Brown JH, Jardetzky T, Saper MA, Samraoui B, Bjorkman PJ, Wiley DC. A hypothetical model of the foreign antigen binding site of Class II histocompatibility molecules. Nature 1988:332:845-850.
34. 34. Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC. X-ray crystal structure of HLA-DR4 (DRA * 0101. DRB1 * 0401) complexed with a peptide from human collagen II. Immunity 1997:7:473-481.
35. 35. Fu XT, et al. Pocket 4 of the HLA DR(αβ 1 * 0401 ) molecule is a major determinant of T cells recognition of peptide. J Exp Med 1995;181:915-926.
36. 36. Hammer J, et al. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med 1995;181:1847-1855.
37. 37. Wucherpfennig KW, et al. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci USA 1995:92:11935-11939.
38. 38. Van Boxel JA, Paget SA. Predominantly T-cell infiltrate in rheumatoid synovial membranes. N Engl J Med 1975;293:517-520.
39. 39. Klareskog L, Forsum U, Scheynius A, Kabelitz D, Wigzell H. Evidence in support of a self-perpetuating HLA-DR dependent delayed-type hypersensitivity reaction in rheumatoid arthritis. Proc Natl Acad Sci USA 1982;79:3632-3636.
40. 40. Janossy G, Panayi G, Duke O, Bofill M, Poulter LW, Goldstein G. Rheumatoid arthritis: a disease of T lymphocyte/macrophage immunoregulation. Lancet 1981;ii:839-843.
41. 41. Yan T, et al. Specificity and T cell receptor β chain usage of a human collagen type II-reactive T-cell clone derived from a healthy individual. Eur J Immunol 1992:22:51-56.
42. 42. Londei M, et al. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci USA 1989;86:636-640.
43. 43. Fugger L, Rothbard JB, Sonderstrup-McDevitt G. Specificity of an HLA-DRB1 * 0401 -restricted T cell response to type II collagen. Eur J Immunol 1996;26:928-933.
44. 44. Rosloniec EF, et al. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med 1997:185:1113-1122.
45. 45. Rosloniec EF, et al. Induction of autoimmune arthritis in HLA-DR4 (DRB1 * 0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol 1998:160:2573-2578.
46. 46. Andersson EC, et al. Definition of MHC and T cell receptor contacts in the HLA-DR4 restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci USA 1998:95:7574-7569.
47. 47. Diab BY, Lambert NC, L'Faqihi FE, Loubet-Lescouli P, de Preval C, Coppin H. Human collagen II peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis. Immunogenetics 1999;49:36-44.
48. 48. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedal B. Immunization against heterologous type II collagen induces arthritis in mice. Nature 1980:283:666-667.
49. 49. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977,146:857-868.
50. 50. Bakker NPM, et al. Experimental immune mediated arthritis in rhesus monkeys. A model for human rheumatoid arthritis? Rheumatol Int 1990;10:21-29.
51. 51. Holmdahl R, Andersson M, Goldschmidt TJ, Gustafsson K, Jansson L, Mo JA. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev 1990;118:193-232.
52. 52. Wooley PH, Luthra HS, Stuart JM, David CS. Type II collagen induced arthritis in mice, I. Major histocompatibility complex (I-region) linkage and antibody correlates. J Exp Med 1981;154:688-700.
53. 53. Holmdahl R, Klareskog L, Andersson M, Hansen C. High antibody response to autologous type II collagen is restricted to H-2q. Immunogenetics 1986;24:84-89.
54. 54. Holmdahl R, et al. Homologous collagen-induced arthritis in rats and mice are associated with structurally different major histocompatibility complex DQ-like molecules. Eur J Immunol 1992;22:419-424.
55. 55. Brunsberg U, et al. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol 1994:24:1698-1702.
56. 56. Andersson M, Holmdahl R. Analysis of type II collagen reactive T cells in the mouse. I. Different regulation of autoreactive versus non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur J Immunol 1990:20:1061-1066.
57. 57. Michaëlsson E, Andersson M, Engström A, Holmdahl R. Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Eur J Immunol 1992;22:1819-1825.
58. 58. Myers L, Terato K, Seyer J, Stuan J, Kang A. Characterization of a tolerogenic T cell epitope of type II collagen and its relevance to collagen-induced arthritis. J Immunol 1992:149:1439-1443.
59. 59. Rosloniec EF. Whittington KB, Brand DD, Myers LK, Stuart JM. Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen-induced arthritis. Cell Immunol 1996;172:21-28.
60. 60. Kjellćn P, et al. The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules. Eur J Immunol 1998.28:755-767.
61. 61. Myers LK, Seycr JM, Stuart JM, Kang AH. Suppression of murine collagen-induced arthritis by nasal administration of collagen. Immunology 1997:90:161-164.
62. 62. Myers LK, et al. Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice. Immunology 1998:95:631-639.
63. 63. Malmstrom V, Michaëlsson E, Burkhardi H, Mattsson R, Vuorio E, Holmdahl R. Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci USA 1996;93:4480-4485.
64. 64. Malmstrom V, Ho KKY, Lun J, Tam PPL, Cheah KSE, Holmdahl R. Arthritis susceptibility in mice expressing human type II collagen in cartilage. Scand J Immunol 1997;45:670-677.
65. 65. Fugger L, Michie SA, Rulifson I, Lock CB, Sonderstrup-McDevitt G. Expression of HL4-DR4 and human CD4 transgenes in mice determines the variable region β-chain T-cell repertoire and mediates an HLA-DR restricted immune response. Proc Nad Acad Sci USA 1994:91:6151-6155.
66. 66. Holmdahl R, Jonsson R, Larsson P, Klareskog L. Early appearence of activated CD4 positive T lymphocytes and la-expressing cells in joints of DBA/1 mice immunized with type II collagen. Lab Invest 1988;58:53-60.
67. 67. Zvaifler NJ. The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 1973:16:265-336.
68. 68. Holmdahl R, Jansson L, Andersson M, Jonsson R. Genetic, hormonal and behavioral influence on spontaneously developing arthritis in normal mice. Clin Exp Immunol 1992;88:467-472.
69. 69. Gonzalez-Gay MA, et al. Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis. J Exp Med 1994;180;1559-1564.
70. 70. Gonzalez-Gay MA, et al. H2-A polymorphism contributes to H2-Eβ-mediated protection in collagen-induced arthritis. Immunogenetics 1996;44:377-384.
71. 71. Gonzalez-Gay MA, et al. Polymorphism of the MHC class II Eb gene determines the protection against collagen-induced arthritis. Immunogenetics 1995;42:35-40.
72. 72. Holmdahl R, Jansson L, Andersson M. Female sex hormones suppress development of collagen-induced arthritis in mice. Arthritis Rheum 1986;29:1501-1509.
73. 73. Anderson GD, Bancrjee S, Luthra HS, David CS. Role of Mls-1 locus and clonal deletion of T-cells in susceptibility to collagen-induced arthritis in mice. J Immunol 1991;147:1189-1193.
74. 74. Wherrett DK, Singer SM, McDevitt HO. Reduction in diabetes incidence in an I-Ag7 transgenic nonobese diabetic mouse line. Diabetes 1997;46:1970-1974.
75. 75. Singer SM, Tisch R, Yang XD, McDevitt HO. An Abd transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells. Proc Natl Acad Sci USA 1993;90;9566-9570.
76. 76. Nabozny GH, et al. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med 1996;183:27-37.
77. 77. Zanelli E, Krco CJ, Baisch JM, Cheng S, David CS. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc Natl Acad Sci USA 1996;93; 1814-1819.
78. 78. Fugger L, Svejgaard A. The HLA-DQ7 and -DQB associations in DR4-positive rheumatoid arthritis patients. A combined analysis of data available in the literature. Tissue Antigens 1997:50:494-500.
79. 79. Woods A, Chen HY, Trumbauer ME, Sirotina A, Cummings R, Zaller DM. Human major histocompatibility complex class II-restricted T cell responses in transgenic mice. J Exp Med 1994.180:173-181.
80. 80. Holmdahl R. Genetics of susceptibility to chronic experimental encephalomyelitis and arthritis, Curr Opin Immunol 1998:10:710-717.
81. 81. Vingsbo C, Jonsson R, Holmdahl R. Avridine-induced arthritis in rats; a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin Exp Immunol 1995;99:359-363.
82. 82. Vingsbo C, Sahlstrand P, Brun JG, Jonsson R, Saxne T, Holmdahl R. Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol 1996;149:1675-1683.
83. 83. Gough A, et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994;37:1166-1170.